Title : [Analgesic effect of dexmedetomidine on oxaliplatin-induced neuropathic pain in rats].

Pub. Date : 2018 Jul 30

PMID : 33168516






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Compared with the rats in the control group, the rats in the model group and Dex+atipamezole group showed significantly decreased PWT and TWL (cold) and increased expression of p-STAT3 in the spinal cord (P < 0.05). Dexmedetomidine signal transducer and activator of transcription 3 Rattus norvegicus
2 In Dex group, PWT and TWL (cold) were significantly increased (P < 0.05) and p-STAT3 expression in the spinal cord was significantly decreased (P < 0.01) 60 to 120 after Dex treatment as compared with those in the model group, and these effects of Dex were significantly attenuated by the administration of atipamezole (P < 0.05). Dexmedetomidine signal transducer and activator of transcription 3 Rattus norvegicus
3 In Dex group, PWT and TWL (cold) were significantly increased (P < 0.05) and p-STAT3 expression in the spinal cord was significantly decreased (P < 0.01) 60 to 120 after Dex treatment as compared with those in the model group, and these effects of Dex were significantly attenuated by the administration of atipamezole (P < 0.05). Dexmedetomidine signal transducer and activator of transcription 3 Rattus norvegicus
4 In Dex group, PWT and TWL (cold) were significantly increased (P < 0.05) and p-STAT3 expression in the spinal cord was significantly decreased (P < 0.01) 60 to 120 after Dex treatment as compared with those in the model group, and these effects of Dex were significantly attenuated by the administration of atipamezole (P < 0.05). Dexmedetomidine signal transducer and activator of transcription 3 Rattus norvegicus
5 CONCLUSIONS: Dex can alleviate oxaliplatin-induced neuropathic pain in rats by inhibiting the phosphorylation of STAT3 in the spinal cord. Dexmedetomidine signal transducer and activator of transcription 3 Rattus norvegicus